Cyclosporine A, Esomeprazole, and Sodium Hyaluronate

The combination of cyclosporine A, esomeprazole, and sodium hyaluronate is not identified as a single formulated product in the provided search results. Instead, these are three distinct medications with individual uses and known interactions. Cyclosporine A is an immunosuppressant used for various conditions including organ transplant rejection prevention, autoimmune disorders, and dry eye disease. Esomeprazole is a proton pump inhibitor used to reduce stomach acid. Sodium hyaluronate is often used in eye drops for dry eye conditions. While studies investigate the combined use of cyclosporine A and sodium hyaluronate specifically for treating dry eye syndrome and post-refractive surgery dry eye disease, and a documented drug interaction exists between cyclosporine and esomeprazole (where esomeprazole can increase the serum concentration of cyclosporine), there is no information about a single formulated product containing all three components together.